Research & Clinical Trials
Championing community-centred, transparent, and equitable infectious disease research through civil society engagement in trial governance and policy.
The Research and Clinical Trials Committee advocates for clinical research that reflects the needs and rights of affected communities. We engage WHO R&D Blueprint, CEPI, and regulatory bodies - developing civil society positions on equitable trial access, community consent, transparent reporting, and research priority-setting. Our work bridges the gap between scientific evidence and the communities whose health depends on it.
🔬
Cross-Cutting
Committes
67
Member Organisations
10
Countries Represented
Stronger
Together for Impact
Evidence
to Policy in Action
+
+
Our Objectives
Ethical Research Practices
Advance ethical practices and equity in clinical trial design, consent processes, and community engagement.
Community Engagement
Promote community engagement and co-authorship in research outputs to reflect local priorities and knowledge.
Patient Advocacy Partnerships
Build partnerships with patient advocacy groups and research networks to amplify community voice in research.
Trial Transparency
Advocate for open, timely publication of clinical trial results — including negative findings — on public registries.
Clinical Trials Dashboard
Support IDA's Clinical Trials Dashboard as a global transparency and accessibility tool for infectious disease trials.
Research Literacy
Strengthen clinical trial literacy among civil society organisations, patients, and communities.
Committee Leadership
Committee Manager
